IPCA LABORATORIES LIMITED

Analyst Reco. Ipca Laboratories Limited

Equities

IPCALAB

INE571A01038

Delayed NSE India S.E. Other stock markets 09:28:44 15/05/2024 BST			5-day change	1st Jan Change
1,269 ^INR	-1.64%		-3.60%	+14.00%

03-29	Ipca Laboratories Limited Announces Cessation of Anand T. Kusre as an Independent Director	CI
03-29	Ipca Laboratories Limited Appoints Swati Arvind Patankar as an Independent Director	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nomura Adjusts IPCA Laboratories Price Target to INR1,308 From INR1,113, Keeps at Buy	02-19	MT
Nomura Upgrades Ipca Laboratories to Buy From Neutral, Adjusts Price Target to INR1,133 From INR942	23/10/23	MT
Nomura Adjusts IPCA Laboratories’ Price Target to INR942 From INR866, Keeps at Neutral	15/08/23	MT
Nomura Adjusts IPCA Laboratories’ Price Target to INR866 From INR911, Keeps at Neutral	20/07/23	MT
Nomura Downgrades IPCA Laboratories to Neutral From Buy, Adjusts Price Target to INR911 From INR1,083	20/02/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer